 |
市場調査レポート
商品コード
300227
世界の単回使用バイオプロセシングシステム市場：2020年～2024年の予測Single-use Bioprocessing System Market by Product, Application, End-users, and Geography - Forecast and Analysis 2020-2024 |
||||||
| 世界の単回使用バイオプロセシングシステム市場：2020年～2024年の予測 |
|
出版日: 2019年10月29日
発行: TechNavio (Infiniti Research Ltd.)
ページ情報: 英文 190 Pages
納期: 即納可能
 |
世界の単回使用バイオプロセシングシステム市場は、2019年から2024年の間に11％を超えるCAGRで成長すると予測されています。低コストで高い生産性を達成するための技術、汚染のリスクを最小限に抑えるための技術、様々な疾患を治療するためのバイオ医薬品の需要などが同市場の成長要因に挙げられます。
当レポートは世界の単回使用バイオプロセシングシステム市場について調査しており、市場動向、成長要因および課題、製品・用途・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。
Technavio's single-use bioprocessing system market analysis considers sales from bags and mixers, bioreactors and fermenters, filtration devices and sampling systems, bioprocess containers, and other products. Our report also provides a detailed analysis of the market Asia, Europe, North America, and ROW. In 2019, the bags and mixers segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as low contamination and the reduction in downtimes by eliminating the need for cleaning validation, will play a significant role in the bags and mixers product segment to maintain its market position. Also, our global single-use bioprocessing system market report looks at factors such as the substantial use of single-use technology to achieve lower costs and higher productivity, the increasing use of single-use technologies to minimize the risk of contamination, and the high demand for biopharmaceuticals to treat various diseases. However, issues related to extractables and leachables in polymeric systems, scale up issues in commercial applications of single-use technologies, and validation issues while selecting suppliers and integrators may hamper the growth of the single-use bioprocessing system industry over the forecast period.
The use of SUB systems in commercial-scale production eliminates the need to perform clean validation and SIP, reducing the cost and time spent on sterilization, maintenance, and cleaning of metal systems. The use of such disposable technologies also reduces the initial costs associated with quality control. Thus, leading to the intense competition among pharmaceutical and biotechnology companies which in turn, increases the need to develop rapid and low-cost capacities without compromising on the quality and safety of products. This leads to the expansion of the global single-use bioprocessing system market at a CAGR of over 11% during the forecast period.
The advanced SUB systems have optimized the production process and eliminated the need for additional manpower. This has led the vendors to start integrating their products with industrial automation platforms such as sensors, probes, processing software, and customizing automation capabilities to suit end-user needs. These developments is expected to have a positive impact on the overall market growth.
For the detailed list of factors that will drive the global single-use bioprocessing system market during the forecast period 2020-2024, view our report.
With the presence of several major players, the global single-use bioprocessing system market is fragmented. Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading single-use bioprocessing system manufacturers, that include 3M Co., Avantor Inc., Compagnie de Saint-Gobain SA, Danaher Corp., Eppendorf AG, General Electric Co., Merck KGaA, Sartorius AG, Solaris Biotechnology Srl., and Thermo Fisher Scientific Inc.
Also, the single-use bioprocessing system market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
比較リスト
